These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
533 related items for PubMed ID: 16949158
1. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors. Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA. Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158 [Abstract] [Full Text] [Related]
2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]
3. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related]
4. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Trans Am Ophthalmol Soc; 2004 Mar; 102():35-44; discussion 44-5. PubMed ID: 15747743 [Abstract] [Full Text] [Related]
5. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ. Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319 [Abstract] [Full Text] [Related]
6. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089 [Abstract] [Full Text] [Related]
7. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA. Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977 [Abstract] [Full Text] [Related]
8. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213 [Abstract] [Full Text] [Related]
9. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G. Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802 [Abstract] [Full Text] [Related]
14. Management and outcome of retinoblastoma with vitreous seeds. Manjandavida FP, Honavar SG, Reddy VA, Khanna R. Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675 [Abstract] [Full Text] [Related]
15. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Shields CL, Shelil A, Cater J, Meadows AT, Shields JA. Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913 [Abstract] [Full Text] [Related]